De Novo Biosynthesis of Sakuranetin in Yarrowia lipolytica Through Systemic Metabolic Engineering
Biotechnology and Applied Biochemistry · 2026
DOI: 10.1002/bab.70082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2026. Verfasst von Jiayun Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Yarrowia, Flavonoids, Metabolic Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation of China, National Key Research and Development Program of China, Shanghai Municipal Science and Technology Major Project.
Abstract (Originalsprache)
The methylated flavonoid sakuranetin, primarily found in barks and leaves, exhibits potent antifungal, antiviral, and anti‐inflammatory effects. Microbial metabolic engineering strategies for its synthesis have gained interest because the extraction of this compound from plants is inefficient. Moreover, whereas the sakuranetin yields from microorganisms remain low, the yeast Yarrowia lipolytica has received recent attention as a promising host cell for compound biosynthesis. In this study, the de novo synthesis of sakuranetin from glucose was achieved in Y. lipolytica through metabolic engineering. First, a synthetic titer of 154.80 mg/L was obtained by introducing methyltransferase into the naringenin‐synthesizing strain. By screening promoters to enhance the expression of methyltransferase, augmenting the supply of the methyl donor SAM, increasing shikimic acid pathway flux, and adjusting the copy number of gene involved in sakuranetin synthesis, the breakthrough sakuranetin titer reached 345.42 mg/L, which was 1.2 times higher than that when using the primary strain. Finally, the strategy to optimize the glucose concentration resulted in a sakuranetin titer that increased to 686.81 mg/L. This paper reports the highest yield of de novo synthesis of sakuranetin by Y. lipolytica , as a potential synthetic chassis for the biosynthesis of naringenin and other flavonoid compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, Zhejiang, China.
- Laboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shang Hai, China.
ORCID-Profile: Wenping Wei, Bang-Ce Ye
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- National Key Research and Development Program of China
- Shanghai Municipal Science and Technology Major Project
Zitieren
APA
Xu, J., Wei, W., Cai, G., Li, M., Qian, T., Chu, X., & Ye, B. C. (2026). De Novo Biosynthesis of Sakuranetin in Yarrowia lipolytica Through Systemic Metabolic Engineering. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.70082
Vancouver
Xu J, Wei W, Cai G, Li M, Qian T, Chu X, et al. De Novo Biosynthesis of Sakuranetin in Yarrowia lipolytica Through Systemic Metabolic Engineering. Biotechnology and Applied Biochemistry. 2026. doi:10.1002/bab.70082
BibTeX
@article{Xu2026,
author = {Xu, Jiayun and Wei, Wenping and Cai, Gaopan and Li, Mengfan and Qian, Tao and Chu, Xiaohe and Ye, Bang-Ce},
title = {De Novo Biosynthesis of Sakuranetin in Yarrowia lipolytica Through Systemic Metabolic Engineering},
journal = {Biotechnology and Applied Biochemistry},
year = {2026},
doi = {10.1002/bab.70082}
}
EUVIMED